Observational Study
Copyright ©The Author(s) 2021.
World J Hepatol. Jan 27, 2021; 13(1): 132-143
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.132
Table 1 Baseline characteristics reported as n (%) or mean (SD)
Variable
Overall cohort (n = 91)
Age51 (12.1)
Sex (male)68 (74.7)
Presenting symptom
Jaundice21 (23.1)
Fever11 (12.1)
Abdominal pain14 (15.4)
Asymptomatic21 (25)
Liver biopsy performed first51 (56)
Percutaneous liver biopsy65 (71.4)
Bile duct diameter (mm)4.6 (1.9)
R factor2 (2.4), Range: 0.1-6.4
Alkaline phosphatase (international units/liter)392.6 (248.4)
AST (units/liter)200.5 (674.8)
ALT (units/liter)205.4 (444.2)
Total bilirubin (mg/dL)4.5 (5.4)
Deceased donor73 (80.2)
Transplant biliary anatomy
Duct-to-duct67 (73.6)
Roux-en-Y hepaticojejunostomy24 (26.4)
Tacrolimus66 (73.3)
Sirolimus20 (22.2)
Everolimus6 (6.6)
Mycophenolate sodium28 (31.1)
Mycophenolate mofetil13 (14.4)
Cyclosporine16 (17.8)
Prednisone20 (22.2)
Immunosuppression monotherapy20 (22)
Dual immunosuppression therapy68 (74.7)
Triple immunosuppression therapy3 (3.3)